Building Connections. Creating Mentorships. Shaping the Future of Sexual Medicine.
In collaboration with AUA FUTURE in Urology™, the SMSNA Medical Student & Resident Committee and Health Advancement & Impact Committee are pleased to present the second annual SMSNA FUTURE in Sexual Medicine Program during the 2026 SMSNA Annual Fall Scientific Meeting in Orlando, Florida.
Designed to foster meaningful connections between the next generation of physicians and leaders in the field, SMSNA FUTURE brings together medical students interested in urology and sexual medicine with urology residents, andrology fellows, and faculty mentors. The goal is to establish mentoring relationships that continue beyond the Annual Meeting. :contentReference[oaicite:1]{index=1}
SMSNA FUTURE Mixer
Friday, October 9, 2026 5:30–6:30 p.m. ET JW Marriott Orlando, Grande Lakes Orlando, Florida
The SMSNA FUTURE Mixer will bring participating mentors and mentees together for an opportunity to meet, connect, and begin building their mentoring relationships.
Participants will have the opportunity to discuss topics important to medical students considering careers in urology and sexual medicine while connecting directly with residents, fellows, and experienced faculty.
Participation in the FUTURE Mixer is reserved for registered mentors and mentees. :contentReference[oaicite:2]{index=2}
Medical Students
Are you a medical student interested in urology or sexual medicine? SMSNA FUTURE offers an opportunity to connect with physicians at different stages of their careers, gain insight into the field, ask questions about training and career pathways, and begin developing professional relationships that can continue long after the Annual Meeting.
SMSNA FUTURE is seeking urology residents, andrology fellows, and faculty who are passionate about mentorship and supporting the education and professional development of medical students and trainees.
As a mentor, you will have an opportunity to share your experiences, answer questions, provide career guidance, and help introduce the next generation to the field.
In addition to the FUTURE Mixer, this year's Annual Meeting will feature additional programming designed for the next generation of sexual medicine professionals.
Junior Faculty Panel Friday, October 9, 2026
Medical Student Session Saturday, October 10, 2026
Additional details will be announced as they become available. :contentReference[oaicite:3]{index=3}
Be Part of the FUTURE
Whether you're a medical student exploring where your career may lead or a physician ready to help guide the next generation, SMSNA FUTURE in Sexual Medicine is about creating connections that last beyond Orlando.
Become a mentee. Become a mentor. Be part of the FUTURE of sexual medicine.
Participants at the SMSNA 27th Annual Fall Scientific Meeting are strongly advised to arrange their own travel-, health- and cancellation insurance in the unfortunate case of having to cancel the meeting participation and/or travel and/or hotel accommodation because of illness or other (personal) circumstances. Neither the SMSNA, SMSNA Executive Office, nor the Organizing Committee or any of their officers, agents, employees or representatives assume any liability whatsoever.
The SMSNA Annual Fall Scientific Meeting is a prime marketing opportunity for you to reach a broad segment of professionals with interests in the field of sexual medicine. As a sponsor or exhibitor of the meeting, you will become highly visible, you will be an integral part of the event and you will gain valuable exposure to key decision-makers and benefit from personal interaction with all attendees. If you are interested to be part of this meeting, please contact Alyssa Miller of the SMSNA Executive Office by email (This email address is being protected from spambots. You need JavaScript enabled to view it.) or phone +1 (952) 683-1917.
The SMSNA recognizes media are major contributors to health and medical coverage worldwide and have the responsibility to keep the general public informed. Distribution and use of advance materials form the SMSNA Annual Fall Scientific Meeting is covered under the SMSNA embargo policy, which is in place to ensure news reporters have the opportunity to write accurate and well-researched news stories on often complex scientific topics, while ensuring publicity does not appear prematurely.
All members of the press as well as abstract authors, public information officers, public relations firms, organizations, local academic or medical institutions and anyone else with access to abstract or research information are required to adhere to SMSNA’s embargo policy. The embargo includes coverage of all research being presented as well as all formats of release, including the Scientific Sessions online itinerary planner, App Abstracts on CD, hard copy Abstract Book (including the supplement to the Journal of Sexual Medicine), online via the Association’s website, and other presentations.
Embargo dates typically reflect the day and time the presentation, meeting or course begins. Coverage of the material is strictly prohibited before this date and time. Embargoed information is not to be made public in any format, including print, television, radio or the internet before the embargo date.
Journalists are not to redistribute the information within or outside their news organizations except for the following condition: journalists may share embargoed information with experts within the field for the purpose of obtaining relevant commentary or quotes. Journalists are responsible for ensuring all third parties honor the embargo date.
Any decision to lift an embargo early is at the sole discretion of the SMSNA. Journalists with questions about the date of an embargo, suspected embargo breaks or whether the embargo has been lifted for whatever reason should contact Tessa Benitez, SMSNA Associate Executive Director, at This email address is being protected from spambots. You need JavaScript enabled to view it. immediately.
The embargo system is based on trust, and the SMSNA appreciates the vast majority of journalists respect the embargo. If you are an editor, please stress the terms of the embargo system with your reporters.
The purpose of the embargo policy is to protect the novelty and integrity of the abstract submissions presented at the Association's Scientific Sessions. This policy recognizes that all submissions are to be considered as preliminary until the time of the presentation or authorized release. Premature release of information contained in any abstract will result in the individual, as well as the employer/affiliated company, institution, organization, etc. being removed from the Scientific Sessions.
Specific Embargo Dates and Times:
Oral Presentations: Abstracts selected for oral presentation are embargoed from the time of submission until the date/time of presentation.
Poster Presentations: Abstracts selected for both moderated as well as unmoderated poster presentation and the respective posters are embargoed from the time of submission until 2:00 pm (local time) of the 1st day of the SMSNA Annual Meeting.
Publication Only: Abstracts selected for publish only are embargoed from the time of submission until 2:00 pm (local time) of the 1st day of the SMSNA Annual Meeting.
Expectations to Embargo Policy - Publicly Traded Companies
A pharmaceutical or device manufacturer that is publicly traded may be advised by its legal counsel that, in order to comply with requirements of the U.S. Securities Exchange Commission (S.E.C.) or a corresponding regulatory body in the country where the company's stock is traded, it must publicly disclose certain data from its submitted abstract prior to the Association's authorized release of the abstract.
Under such extenuating circumstances, and upon appropriate request, the SMSNA may grant an exception to its embargo policy and allow the company to release limited top line data from the abstract without jeopardizing its eligibility to be presented at the Association's Scientific Sessions. To request such an exception, a letter stating that disclosure of the information is necessary to comply with applicable securities laws needs to be sent via email to Tessa Benitez, SMSNA Associate Executive Director, at This email address is being protected from spambots. You need JavaScript enabled to view it. and copy the corresponding author of the abstract.
The Association will evaluate these requests on a case-by-case basis and reserves the right to change the type of presentation (from oral presentation to poster presentation) or remove the abstract from the meeting program if it determines that the released information may substantially detract from the novelty of the annual meeting presentation.
Questions regarding the correct embargo dates/times for the Association's Scientific Sessions should be addressed to Tessa Benitez, SMSNA Associate Executive Director, at This email address is being protected from spambots. You need JavaScript enabled to view it.
Moderators:
Marah Hehemann, MD & Matthew Ziegelmann, MD
1:00 PM - 1:05 PM
Welcome and CME Introduction
Speakers:
Marah Hehemann, MD & Matthew Ziegelmann, MD
1:05 PM - 1:20 PM
AUA Lecture - United We Stand: A Winning Advocacy Story
Speaker:
Maureen Cones
1:20 PM - 1:40 PM
13th Annual Robert Krane Lecture - 1992 NIH Consensus Conference on Impotence - Have we met the Challenge?
Speaker:
Gregory Broderick, MD
1:40 PM - 2:00 PM
2nd Annual Steven Wilson Lecture on Prosthetic Urology - The Legacy of Mentorship
Speaker:
Tobias Kohler, MD, MPH
2:00 PM - 3:30 PM
Palazzo Ballroom A-B
Basic Science Abstract Session
Moderators:
Kelvin Davies, MSc, PhD, Johanna Hannan, PhD & Justin La Favor, PhD
2:00 PM - 2:06 PM
Vulvovaginal Obliteration: A Severe Manifestation of Sexual Inactivity Syndrome of Menopause (#001)
Speaker:
Ziomara Machado
2:06 PM - 2:12 PM
Long-Term Impact of Prepubertal Leuprolide Acetate Treatment on the Estrous Cycle and Vaginal Morphology (#002)
Speaker:
Johanna Hannan, PhD
2:12 PM - 2:18 PM
Agreement Between Enzyme-Linked Immunosorbent Assay and Liquid Chromatography–Tandem Mass Spectrometry for Serum Testosterone Measurement in Women (#003)
Speaker:
Jamie Welsh
2:18 PM - 2:24 PM
Late Initiation of Hormone Replacement Therapy in Menopause (#004)
Speaker:
Lelia Yousif
2:24 PM - 2:30 PM
Why Sexual Medicine Specialists Must Understand Hormone Replacement Therapy (#005)
Speaker:
Alberto Dominguez-Bali
2:30 PM - 2:36 PM
Treatment Patterns and Reported Outcomes Among Patients with Anorgasmia: A Descriptive Retrospective Study (#006)
Speaker:
Alfonso Gudino Villarreal
2:36 PM - 2:42 PM
FSH Bioactivity is Impaired Per Immunoassay Unit in Men with Non-Obstructive Azoospermia: Proof-of-Concept Using a Cell-Based Functional Assay (#012)
Speaker:
Corey Able
2:42 PM - 2:48 PM
Sertoli Cells in Non-Obstructive Azoospermia Switch from FSH-Responsive to FSH-Resistant States: Evidence from Single-Cell Transcriptomic Analysis of Two Independent Human Testicular Datasets (#007)
Speaker:
Corey Able
2:54 PM - 3:00 PM
SHH/BMP4/GREM1 Regulate a Universal Remodeling Mechanism in the Penis (#010)
Speaker:
Byungcheol So
3:00 PM - 3:06 PM
Novel Pegylated-Nanoparticle Delivery of Stromal Derived Factor-1 mRNA Recovers Erectile Function and Blunts Pro-Contractile Proteins in Type 2 Diabetic Rats (#011)
Speaker:
Johanna Hannan, PhD
3:12 PM - 3:18 PM
A Distinct Leydig Cell Steroidogenic Endotype in Non-Obstructive Azoospermia: Single-Cell Transcriptomic Discovery and Clinical Validation (#013)
Speaker:
Taylor Kohn, MD
3:24 PM - 3:30 PM
Fidgetin-like 2 (FL2) Regulates Cavernous Nerve Regeneration, Angiogenesis, and Immune Cell Recruitment after Injury (#015)
Speaker:
Olga Vafaeva
2:00 PM - 3:30 PM
Palazzo Ballroom C
Basics of Sexual Medicine for the Mental Health Provider - Part 1
Moderator:
Claire Postl, LPCC
2:00 PM - 2:05 PM
Introduction and Disclosures
Speaker:
Claire Postl, LPCC
2:05 PM - 2:25 PM
Cancer Survivorship and Sexual Function Changes
Speaker:
Chiara Acquati, PhD, LMSW, FAOSW
2:25 PM - 2:45 PM
Penile Disorders and Urological Conditions that impact sexual function
Speaker:
Bruce Kava, MD, MSCTI
2:45 PM - 3:05 PM
What Does a Mental Health Provider Need to Know about Products, Pills, and Procedures from a Medical Perspective
Speaker:
Amy Pearlman, MD
3:05 PM - 3:25 PM
Vulvar Disorders — Introduction and Implications for Mental Health
Speaker:
Rachel Needle, PsyD
3:25 PM - 3:30 PM
Q&A
2:00 PM - 3:30 PM
Palazzo Ballroom F-H
VJSM Video Abstract Session Part 1 - Penile implants/Peyronie's Disease
Moderators:
David Barham, MD & Faysal Yafi, MD, FRCSC
2:00 PM - 2:05 PM
Introduction
2:05 PM - 2:15 PM
Tips and Tricks for Plaque Excision and Grafting in Peyronie's Disease (#132)
Speaker:
Kian Asanad, MD
2:15 PM - 2:25 PM
Modification of Duckett/Baskin Tunica Albuginea Plication (TAP) Technique (#133)
Speaker:
Laurence Levine, MD
2:25 PM - 2:35 PM
Reservoir Herniation Following Inflatable Penile Prosthesis Implantation After Radical Prostatectomy: Step-by-Step Subrectus Reservoir Repositioning (#134)
Speaker:
Kareim Khalaf Alla
2:35 PM - 2:45 PM
Radial Corporoplasty Repair of Christmas Tree Deformity: A Rare Presentation of Tunical Attenuation and Aneurysmal Corporal Dilatation (#135)
Speaker:
Ahmed Elauri
2:45 PM - 2:55 PM
The Rabacus: A Novel Real-Time Dynamic Measuring Tool for Accurate Malleable Penile Prosthesis Sizing (#136)
Speaker:
Ahmed Ragheb, MD
2:55 PM - 3:05 PM
Avoiding the Space of Retzius and Incomplete Inguinal Entry: A Safe Submuscular Approach for Inflatable Penile Prosthesis Reservoirs (#137)
Speaker:
Mohammed Hamdan
3:05 PM - 3:15 PM
Removal and Replacement of Inflatable Penile Prosthesis with Bilateral Distal Extracapsular Tunneling, Distal Biologic Cap and Distal Anchoring Sutures for Concurrent Impending Erosion and Corporal Fibrosis (#138)
Speaker:
Kareim Khalafalla, MD
2:00 PM - 3:30 PM
Mediterranean Ballroom 1-3
Lifestyle, Medicine, and Sexual Health Part 1
Moderators:
Lawrence Hakim, MD, FACS & Carolyn Salter, MD
2:00 PM - 2:15 PM
Why is it Important That We Have a Federal Office of Men's Health?
Speaker:
Nahid Punjani, MD, DrPH, FRCSC
2:15 PM - 2:30 PM
Sexual Function as a Barometer of Cardiovascular Health - Updates from the Princeton V Consensus Guidelines (Male and Female)
Speaker:
John Mulhall, MD, MSc, FECSM, FACS, FRCSI
2:30 PM - 2:40 PM
Menopause, Lifestyle, and Sexual Health: Non-Hormonal Strategies
A Muscle-First Approach to Sexual Health: Skeletal Muscle as an Overlooked Therapeutic Target
Speaker:
Gabrielle Lyon, DO
3:15 PM - 3:30 PM
Q&A
3:30 PM - 4:00 PM
Foyer - Poster Station 1
E-Poster Session 1 - Epidemiology/Risk Factors I
Moderator:
Kenneth Delay, MD
3:30 PM - 3:33 PM
Association Between Systemic Oral Corticosteroid Use and Peyronie's Disease: A Cross-Sectional Claims-Based Study of 1.48 Million United States Adult Males (#146)
Intracavernosal Xeomin as Adjunctive Therapy to On-Demand Tadalafil for Mild-to-Moderate ED: Rationale, Design, and Hypotheses of a Randomized Crossover Pilot Study (#160)
Acute Effects of Combined Sublingual Testosterone and Sildenafil on Clitoral Blood Flow in Premenopausal Women with Acquired Generalized FSIAD: A Randomized Open-Label Dose-Response Study (#163)
Timing Matters: Preoperative Penile Rehabilitation and Erectile Recovery After Prostatectomy — Preliminary Results from an IU Randomized Controlled Trial (#026)
Speaker:
Helen Bernie, DO, MPH
4:11 PM - 4:17 PM
Erectile Dysfunction as an Independent Predictor of Retinal Microvascular Disease: A Propensity Score-Matched Cohort Study (#017)
Speaker:
Zaid Ahmed
4:17 PM - 4:23 PM
Effect of GLP-1 Receptor Agonists on Erectile Dysfunction Outcomes Compared to Existing Type 2 Diabetes Monotherapies (#018)
Speaker:
Ashley Wang
4:23 PM - 4:29 PM
A Prospective Single-Arm Study of Endovascular Polidocanol Foam for Venous Leak Erectile Dysfunction (#019)
Speaker:
Michael Pignanelli, MD
4:29 PM - 4:35 PM
Quantitative Ultrasound Mapping of Corporal Fibrosis: Early Validation of High-Frequency Imaging Against Histologic Collagen Content in Men Undergoing Penile Prosthesis Surgery (#020)
Speaker:
Beatriz Hernandez
4:35 PM - 4:41 PM
Cardiovascular Risk Assessment Following Incident Erectile Dysfunction Diagnosis: A Nationwide Real-world Analysis Using Epic Cosmos (#021)
Speaker:
Christabel Egemba
4:41 PM - 4:47 PM
Long-term Safety and Efficacy of Tunodafil Hydrochloride in Men with Erectile Dysfunction: A 12-Month Multicenter Open-Label Study (#022)
Speaker:
Yuzhuo Yang
4:47 PM - 4:53 PM
Quantitative Ultrasound Texture Analysis Using Nakagami and Entropy-Based Metrics in Men Undergoing Penile Duplex Doppler Ultrasound (#023)
Speaker:
Beatriz Hernandez
4:53 PM - 4:59 PM
Durability of Erectile Function Improvement Following Li-ESWT (#024)
Speaker:
Leona Hariharan
4:59 PM - 5:05 PM
Multicenter Provider-Reported Outcomes of the P-Long Protocol in 792 Men Across 17 Practices (#025)
Speaker:
Judson Brandeis
5:05 PM - 5:11 PM
Phosphodiesterase-5 Inhibitor Use is Associated with Reduced Calcineurin Inhibitor Toxicity and Improved Graft Outcomes in Solid Organ Transplant Recipients (#016)
Speaker:
Jolie Shen
4:05 PM - 5:15 PM
Palazzo Ballroom C
Basics of Sexual Medicine for the Mental Health Provider - Part 2
Moderator:
Claire Postl, LPCC
4:05 PM - 4:20 PM
Pelvic Floor Physical Therapy: Treatment of Pelvic Floor Dysfunction in Men and Women
Neighborhood Deprivation and Racial Disparities in Time to Treatment Initiation for Erectile Dysfunction: A National Analysis Using the NIH All of Us Research Program (#188)
Multidimensional Self-Perceived Health Reveals Hidden Sexual and Psychosocial Burden in Women with Pelvic Organ Prolapse: Findings from the All of Us Research Program (#190)
Sex, the Best Natural Practice to Preserve the Genitourinary System and Prevent Genitourinary Syndrome of Menopause: Therapeutic, Molecular, and Cellular Mechanisms (#194)
Medical, Obstetrical, Gynecological, and Sexual Consequences of Massive Immigration to the United States and Its Role in the Maintenance of Women’s Sexual Health (#195)
Bridging the Gap in Female Sexual Health: Addressing Global Regulatory Disparities and Access Inequities in Postmenopausal Hypoactive Sexual Desire Disorder (#201)
Speaker:
Guanjian Li
10:00 AM - 10:30 AM
Foyer - Poster Station 3
E-Poster Session 8 - Orgasm/Ejaculation Disorders in Men
Moderator:
Michael Pignanelli, MD
10:00 AM - 10:03 AM
Multimodal Digital Neuromuscular Rehabilitation for Premature Ejaculation: A Prospective Pilot Study (#202)
Impact of Patient Understanding of Sexual Side Effects and Risks of Surgical Interventions for Benign Prostatic Hyperplasia on Outcome Satisfaction and Decisional Regret (#203)
Treatment Utilization and Patient-Reported Outcomes in Men with Delayed Ejaculation, Anorgasmia, and Premature Ejaculation: Data from the CLIMAX Registry (#204)
Pharmacotherapy Utilization and Clinical Management Patterns in Men with Premature Ejaculation: A Nationwide Real-world Analysis Using Epic Cosmos (#207)
Partners of Patients with Benign Prostatic Hyperplasia May Prioritize Symptom Relief over Preservation of Ejaculation: Preliminary Results from a Prospective Survey Study (#209)
Moderators:
Gregory Broderick, MD & Nicholas Deebel, MD
10:35 AM - 10:41 AM
Minimally Invasive BPH Procedures Dominate Contemporary U.S. Practice, With Regional Variation in Erectile Dysfunction Treatment Cohorts Across AUA Sections: Initial Insights from the AUA AQUA Registry (#027)
Speaker:
Muhammed A Moukhtar Hammad
10:41 AM - 10:47 AM
Toward Personalized Risk Assessment After IPP Surgery: Explainable Machine Learning for Predicting Non-infectious Complications Utilizing a Large Multicenter Collaborative (#028)
Speaker:
Muhammed A. Moukhtar Hammad
10:47 AM - 10:53 AM
Support Without Comfort: Adult Female Patient Perspectives on Male Trainee Involvement in Pelvic and Sexual Health Visits (#029)
Speaker:
Jessica Yih, MD
10:53 AM - 10:59 AM
A Stain on Our History: The Forensic Origins of the Azoospermia Prevalence Myth (#030)
Speaker:
Corey Able
10:59 AM - 11:05 AM
Female Sexual Dysfunction in Sexual Medicine Fellowship Training: Perspectives of Fellowship Directors (#031)
Speaker:
Theodora Zavos
11:05 AM - 11:11 AM
Implementation of an American Urological Association Guideline-Directed Annotation to Testosterone Laboratory Orders in an Electronic Medical Record (#055)
Speaker:
Claire Haas
11:11 AM - 11:17 AM
Associations between Penile Duplex Ultrasound Parameters and Coronary Artery Calcium Scores in Men with Erectile Dysfunction (#033)
Comparative Outcomes of T-Shunt Surgery and Penoscrotal Decompression in Refractory Ischaemic Priapism: The Impact of Time on Detumescence and Corporal Viability (#034)
Speaker:
Abdullah Al-Mitwalli
11:23 AM - 11:29 AM
Penile Duplex Doppler Ultrasound Findings Under a Standardized Rigidity-Based Redosing Protocol (#035)
Speaker:
Hasim Bakbak
11:29 AM - 11:35 AM
Insurance Status and Barriers to Timely Male Infertility Diagnosis (#036)
Speaker:
Fortis Gaba
11:35 AM - 11:41 AM
Reassessing Body Mass Index as a Predictor of Intraoperative and Postoperative Non-infectious Complications After Inflatable Penile Prosthesis Surgery: A Multicenter Analysis (#037)
Speaker:
Marilyn Jones
11:41 AM - 11:47 AM
Current E-Cigarette Use Is Associated With a 66% Lower Total Motile Sperm Count Among Men Seeking Fertility Evaluation (#038)
Speaker:
Nikola Rakic
11:47 AM - 11:53 AM
Novel Use of Penile Thermography for Assessment of Glans Penis Temperature in Patients with Symptoms of Hard Flaccid Syndrome (#039)
Speaker:
Irwin Goldstein, MD, IF
11:53 AM - 11:59 AM
Incidence and Development of Female Sexual Dysfunction in Partners of Patients Entering Penile Rehabilitation Programs After Nerve-Sparing Prostatectomy (#040)
Practical Applications From the 2025 Management of Male Chronic Pelvic Pain AUA Guideline - What Every Sexual Health Clinician Should Know
Speaker:
Susan MacDonald, MD
10:50 AM - 11:05 AM
Surgical Management of Chronic Scrotal Content Pain - Choosing the Right Approach for the Right Patient
Speaker:
Trenton Barrett, MBBS, FRACS
11:05 AM - 11:20 AM
Genital Pain Mimics - Case-Based Differential Diagnosis of NPV, GSM, Tarlov Cysts, and Pudendal Neuralgia
Speaker:
Jessica Yih, MD
11:20 AM - 11:45 AM
Panel: "Lichen Sclersus - A Dual Perspective From Dermatologic to Psychosexual Sequelae
Mentors:
Jill Krapf, MD, Med, IF & Rachel Needle, PsyD
11:45 AM - 12:00 PM
Q&A
12:15 PM - 1:15 PM
Mediterranean Ballroom 4
Industry Sponsored Lunch Symposium (Non-CME)
1:30 PM - 3:00 PM
Palazzo Ballroom F-H
VJSM Video Abstract Session Part 2 - FSD, Infertility & Gender Affirming Care
Moderators:
Cassandra Lyons, MD & Jessica Yih, MD
1:30 PM - 1:35 PM
Introduction
1:35 PM - 1:45 PM
Step-by-Step Modified End-to-Side Vasoepididymostomy in the Office Setting (#139)
Speaker:
Ellen Cahill, MD
1:45 PM - 1:55 PM
Novel Application of Acellular Dermal Matrix for Primary Neovaginal Canal Formation in Penile-Inversion Vaginoplasty: a Surgical Demonstration and Case Series (#140)
Speaker:
Vincent Hou
1:55 PM - 2:05 PM
Clitoral Cyst Excision and Clitoral Reconstruction (#141)
Speaker:
Noel Higgason
2:05 PM - 2:15 PM
Lysis of Clitoral Adhesions with Complete Prepuce Fusion: An In-Office Procedure (#142)
Speaker:
Leona Hariharan
2:15 PM - 2:25 PM
Vulvodynia: A Stepwise Clinical Approach to Diagnosis and Treatment (#143)
Speaker:
Leona Hariharan
2:25 PM - 2:35 PM
Testosterone Therapy for Women: A Practical Approach to Prescribing, Formulation, and Compounding (#144)
Speaker:
Jessica Yih, MD
2:35 PM - 2:45 PM
Removal of Male Penile Size Enhancement Device and Capsulectomy (#145)
Speaker:
Sarah Armitage
1:30 PM - 3:30 PM
Palazzo Ballroom A-B
Androgens Abstract Session
Moderators:
Larry Lipshultz, MD & Niki Parikh, MD, MBA, MSBA
1:30 PM - 1:36 PM
Testosterone Replacement Therapy for Critical Illness-Associated Hypogonadism in Tracheostomized ICU Patients: A Retrospective Safety Analysis (#042)
Speaker:
Ahmed Shoeib
1:36 PM - 1:42 PM
GLP-1 Receptor Agonist Prescription Is Associated with Higher Serum Testosterone in Obese Non-Diabetic Men: A Propensity Score Matched Cohort Study (#041)
Speaker:
Aaron Gurayah
1:42 PM - 1:48 PM
Digital Sleep Phenotyping in Hypogonadal Men Receiving Testosterone Therapy (#043)
Speaker:
Zaid Ahmed
1:48 PM - 1:54 PM
The Rise of Testosterone Therapy Utilization: Specialty-Specific Prescribing Pattern in Primary Care, Endocrinology, and Urology (#059)
Speaker:
Alex Tsobanoudis
1:54 PM - 2:00 PM
Kyzatrex (Oral Testosterone Undecanoate) Use in Men with Testosterone Deficiency is Associated with High Compliance and Lower Rates of Phlebotomy Relative to Other Forms of Testosterone-Replacement Therapy (#045)
Speaker:
Efemona Famati
2:00 PM - 2:06 PM
Association of Aromatase Inhibitor Use With Osteoporosis Risk in Men Receiving Testosterone Therapy (#046)
Speaker:
Samy Sasoun
2:06 PM - 2:12 PM
Impact of Obstructive Sleep Apnea on Hormonal Recovery After Clomiphene Citrate Therapy in Men With Testosterone Deficiency (#047)
Speaker:
Hasim Bakbak
2:12 PM - 2:18 PM
Enclomiphene Use Among Men with Hypogonadism: A Qualitative Analysis of Online Discussion Communities (#048)
Speaker:
Allison Meling
2:18 PM - 2:24 PM
When Guidelines Disagree: How Diagnostic Heterogeneity in Testosterone Deficiency Creates Barriers to Patient Care (#049)
Speaker:
Allison Meling
2:24 PM - 2:30 PM
A Real-World Analysis of Laboratory Monitoring Patterns and Prescribing Trends for Testosterone Therapy (#050)
Speaker:
Kiera Liblik
2:30 PM - 2:36 PM
Impact of Military Operational Stress on Testosterone Levels (#051)
Speaker:
Trevor Maloney
2:36 PM - 2:42 PM
Assessing the Risk of Pulmonary Embolism, Venous Thromboembolisms, and Initiation of Anti-Coagulation in Men Receiving Testosterone Replacement Therapy (#052)
Speaker:
Corey Able
2:42 PM - 2:48 PM
HERBS: Clinical Consequences of Supraphysiologic Testosterone (>1000 ng/dL): A Review of known Sequelae and Implications (#053)
Speaker:
Ethan Low
2:48 PM - 2:54 PM
Effect of GLP-1 Receptor Agonists on Sexual and Hormonal Outcomes in Men With Obesity-Associated Functional Hypogonadism: A Systematic Review and Single-Arm Meta-Analysis (#054)
Speaker:
Fernando Loyola-Nieto
2:54 PM - 3:00 PM
Beyond Muscle: The Multi-System Adverse-Effect Profile of Anabolic–Androgenic Steroids (#060)
Speaker:
Ethan Low
3:00 PM - 3:06 PM
Adjunctive Human Chorionic Gonadotropin During Testosterone Replacement: A Propensity-Matched Evaluation of Symptomatic Outcomes (#056)
Speaker:
Beatriz Hernandez
3:06 PM - 3:12 PM
Age-Specific Reference Ranges for Total Testosterone in Males: A Systematic Review and Pooled Analysis of 261,985 Men (#057)
Speaker:
Shane Kronstedt
3:12 PM - 3:18 PM
Clomiphene Citrate Preserves Gonadotropin Activity and Demonstrates Age-Dependent Testosterone Response in Men with Functional Hypogonadism: A Real-World Comparative Study (#058)
Speaker:
Min Gu Park
3:18 PM - 3:24 PM
Oral Testosterone Undecanoate Effectively Increases Serum Testosterone and Improves Sexual Activity Across All BMI Groups (#044)
Speaker:
Ellen Cahill, MD
3:24 PM - 3:30 PM
Low Total Testosterone Predicts Worse Erectile Function Recovery following Radical Prostatectomy (#032)
Speaker:
Daniel Kim
1:30 PM - 3:30 PM
Mediterranean Ballroom 1-3
All About The Penis: Disorders of Penile Erection
Moderators:
Marah Hehemann, MD & Wayne Hellstrom, MD, FACS
1:30 PM - 1:45 PM
Multi-Surgeon Clinical Datasets - What We've Learned and What the Future Holds
Speaker:
David Barham, MD
1:45 PM - 2:00 PM
Erection Aids (VED, Constrictions Bands, and Beyond): How Do I Help My Patient Choose the Right Product to Optimize Sexual Function?
Speaker:
Jonathan Beilan, MD
2:00 PM - 2:20 PM
Panel: How Do We Effectively Deliver the Diagnosis of Psychogenic ED and Propose Treatment Plans That Engage Our Mental Health Colleagues?
Moderator:
Christian Nelson, PhD
Mentors:
Robert Denton, PsyD, ABS, Christian Nelson, PhD & Nannan Thirumavalavan, MD
2:20 PM - 2:35 PM
Genital Anesthesia - Practical Anatomy and Applications for In-Office Surgical Procedures
Speaker:
Sung Hun (Sean) Park, MD
2:35 PM - 2:50 PM
CCH Modifications - Are These Really Improving Outcomes for Our Patients and at What Cost?
Speaker:
Majdee Islam, MD
2:50 PM - 3:20 PM
Panel: Beyond the Curve - Managing Penile Shortening, Pain, and Indentation Deformity in Peyronie's Disease
Moderator:
William Brant, MD, FACS, FECSM
Mentors:
Raevti Bole, MD, Lawrence Jenkins, MD, MBA, FACS & Matthew Ziegelmann, MD
3:20 PM - 3:30 PM
Q&A
3:30 PM - 4:00 PM
Foyer - Poster Station 1
E-Poster Session 11 - Androgens
Moderator:
Daniel Pelzman, MD
3:30 PM - 3:33 PM
Effect of GLP-1 Receptor Agonists Versus Testosterone Replacement Therapy on Hormonal and Sexual Outcomes in Men with Obesity-Associated Functional Hypogonadism: A Systematic Review and Meta-Analysis (#226)
Duloxetine and Suicidal Ideation Risk in Men with Orchialgia: A Propensity-Matched Comparison With Amitriptyline Reveals a Significant Safety Signal (#237)
Pudendal Neuralgia as an Underrecognized Cause of Male Sexual Dysfunction and Chronic Pelvic Pain: A Contemporary Evidence Review (#238)
Speaker:
Shushant Shandilya
3:45 PM - 3:48 PM
Comparative Safety of Duloxetine Versus Gabapentin in Men With Orchialgia: A Propensity Score-Matched Analysis of Psychiatric, Sexual, and Systemic Adverse Outcomes (#239)
Is There an Optimal Window for Penile Prosthesis Implantation? The Impact of Erectile Dysfunction Duration on Satisfaction, Quality of Life, and Decision Regret (#243)
A Multi-Phase Perioperative Antimicrobial Protocol for Primary Inflatable Penile Prosthesis Implantation: Achieving a 0.5% Infection Rate Across 1,500 Cases at a High-Volume Center (#246)
Speaker:
Mohammed Hamdan
3:45 PM - 3:48 PM
Use of Narrow Base Inflatable Penile Prosthesis: A 10-Year Retrospective Analysis (#247)
Post-Operative Complications Following Penile Prosthesis Implantation in Patients Using Testosterone Supplementation: A Retrospective Claims-Based Cohort Study (#248)
Erectile Function Outcomes and Predictors of Clinically Meaningful Response to Low-Intensity Extracorporeal Shockwave Therapy in Predominantly Severe Erectile Dysfunction (#250)
Finasteride and Dutasteride Are Not Associated with Increased Rates of Sexual Dysfunction Compared to Alpha-Blocker Controls: A Propensity Score-Matched TriNetX Analysis (#251)
Semaglutide Use Is Associated with Erectile Dysfunction and Hypogonadism Compared with Tirzepatide and Other Weight Loss Medications in Obese, Non-Diabetic Men: A Propensity Score–Matched Analysis (#255)
Bridging Biomedical and Psychosocial Silos with the Sexual Tipping Point® Model: Interactive Tools for Integrated Sexual Medicine Clinical Training (#260)
Foreskin Tissue Expander as a Non-Invasive Alternative: Comparative Outcomes from Australian and UK Prospective Studies (#263)
Speaker:
Zhong Li Titus Lim
3:48 PM - 3:51 PM
Delayed Sleep Timing Chronotype Is Associated with Lower Morning Testosterone Among U.S. Men: Analysis of Wearable Device Data from the NIH All of Us Program (#264)
Great Debates: Controversies in Disorders of Penile Erection
Moderators:
Helen Bernie, DO, MPH, Arthur Burnett, MD, MBA, FACS & Christian Nelson, PhD
4:05 PM - 4:30 PM
PDE5-Inhibitors Should Be Offered Over the Counter
Moderator:
Trinity Bivalacqua, MD, PhD
Speakers:
Thomas Masterson, MD & Landon Trost, MD
4:30 PM - 4:55 PM
Penile Implant Should Be Offered Early for Post-Prostatectomy Erectile Dysfunction
Moderator:
Aram Loeb, MD
Speakers:
John Mulhall, MD, MSc, FECSM, FACS, FRCSI & Run Wang, MD, FACS
4:55 PM - 5:20 PM
Management of ED and PD With IPP - Less Is More or Maximal Therapy to Optimize Side/Deformity Correction
Moderator:
Billy Cordon-Galiano, MD
Speakers:
Martin Gross, MD & Laurence Levine, MD
5:20 PM - 5:30 PM
Q&A
4:05 PM - 5:30 PM
Palazzo Ballroom A-B
Innovations in Sexual Medicine Abstracts (Non-CME)
Moderators:
Justin Dubin, MD & Gerard Henry, MD
4:05 PM - 4:11 PM
Collagenase Clostridium Histolyticum For Ventral Curvature of the Penis Due to Peyronie’s Disease: Subgroup Analysis of a Multicenter Retrospective Phase 4 Observational Study (#083)
Speaker:
Billy Cordon-Galiano, MD
4:11 PM - 4:17 PM
Vaginal Dryness Occurrences During Drospirenone 4mg Usage in Adults: Results from Three Phase III Clinical Trials (#075)
LIB-01: PART I - Durable Pro-Erectile Effects Involving Transcriptional Modulation of the Melanocortin System (#076)
Speaker:
Charlotta Gauffin
4:23 PM - 4:29 PM
LIB-01: Part II - A Novel First‑in‑Class Oral Investigational Therapy for Erectile Dysfunction with Demonstrated Clinically Meaningful Improvements In Erectile Function and Duration of Action up to 8 Weeks (#077)
Speaker:
Harin Padma-Nathan
4:29 PM - 4:35 PM
LIB-01: Part III - A Phase 2b trial Design Adapted to a Molecule with a Novel Mechanism and Durable Pharmacodynamic Profile (#078)
Speaker:
Arthur L Burnett
4:35 PM - 4:41 PM
Engineering Evaluation of the New Titan Prime Inflatable Penile Prosthesis: Maintenance of Structure Equivalence and Improvement in Flaccid State Performance (#079)
Speaker:
Irwin Goldstein, MD, IF
4:41 PM - 4:47 PM
Kink-Resistant Tubing: Abrasion Resistance Testing of Bioflex-Coated Versus Uncoated Silicone Tubing (#080)
Speaker:
Irwin Goldstein, MD, IF
4:47 PM - 4:53 PM
An Open-Label, Single-Dose, Randomized, Parallel-Cohort Study of the Safety and Relative Bioavailability of Topical Sildenafil Cream, Versus Oral Sildenafil in Healthy Male Adults (#081)
Speaker:
Andrea Thurman
4:53 PM - 4:59 PM
Evaluating the Next Generation of Implantable Penile Prostheses: Cadaveric Assessment of Titan Prime (#082)
Speaker:
Pedro Maria, DO
4:59 PM - 5:05 PM
Titratable Oral Testosterone Undecanoate Increases and Normalizes Testosterone in Men ≥65 Years Old with Hypogonadism (#084)
Speaker:
Martin M. Miner
5:05 PM - 5:11 PM
Qualitative Development of a Brief, Integrated, Patient- and Provider-Informed Screening Tool for Peyronie’s Disease, Erectile Dysfunction, and Low Testosterone (#085)
Speaker:
Majdee Islam, MD
5:11 PM - 5:17 PM
The Efficacy of Sacral Neuromodulation for LUTS in Three Cohorts of Male Patients with Overactive Bladder: Trial Methodology (#086)
Speaker:
Adam Baumgarten, MD, MBA
5:17 PM - 5:23 PM
Collagenase Clostridium Histolyticum For Ventral Curvature of the Penis Due to Peyronie’s Disease: Literature Review of Real-World and Multicenter Phase 4 Outcomes (#087)
Speaker:
Jesse Mills, MD
5:23 PM - 5:29 PM
Economic and Practice Efficiency Impact of Reconstructive Urologist and Advanced Practice Provider-Supported Care After Radical Prostatectomy in Prostate Cancer Patients (#088)
Speaker:
Andrew Sun
4:05 PM - 5:30 PM
Palazzo Ballroom C
FSD, Mental Health, Special Populations Abstracts
Moderators:
Alexis Chesrow, MD, FPMRS & Sue Goldstein, BA, CCRC, AASECT-CSE, IF
4:05 PM - 4:11 PM
Acceptant & Commitment Therapy (ACT) Increases Compliance with Sexual Dysfunction Treatments in Men with Prostate Cancer: 6 & 12-Month Data from a Randomized Controlled Trial (#061)
Speaker:
Christian Nelson, PhD
4:11 PM - 4:17 PM
Longitudinal Progression of Erectile Dysfunction in Parkinson’s Disease and Its Association with Cognitive Decline (#062)
Speaker:
Edward Ofori
4:17 PM - 4:23 PM
Prevalence and Impact of Depression in Men with Delayed Ejaculation and Anorgasmia: A Prospective Registry Analysis Using the Beck Depression Inventory (#063)
Speaker:
Grace H. Holton
4:23 PM - 4:29 PM
Pelvic Exam and Pap Smear Experiences Among Queer-Identified Cisgender Women with Genitopelvic Pain (#064)
Speaker:
Olivia Adams
4:29 PM - 4:35 PM
Utilization and Prescribing Pattern Dynamics of Genitourinary Syndrome of Menopause Therapies in the United States: A Medicare Part D Analysis (2013–2023) (#065)
Speaker:
Valeria Pierluissi
4:35 PM - 4:41 PM
Assessing the Triad of Dysautonomia, Hypermobility Spectrum Disorders, and Mast Cell Activation Syndrome in Patients with Sexual Dysfunction: A Novel Framework (#066)
Speaker:
Aditi Prabhu
4:41 PM - 4:47 PM
Integrated Therapeutic Approaches to Improve Erectile Function and Quality of Life in Hard Flaccid Syndrome (#067)
Speaker:
Christopher Mendias
4:47 PM - 4:53 PM
A Comparative Study of Gel and Injection Testosterone Therapy in Femles: Clinical Outcomes and Adverse Event Rates in a Retrospective Cohort Study (#068)
Speaker:
Peyton Coady
4:53 PM - 4:59 PM
Educational Intervention Improves OB/GYN Residents’ Competency in Postmenopausal HSDD (#069)
Speaker:
Guanjian Li
5:05 PM - 5:11 PM
Characteristics of Couples with Vaginal Orgasms (#071)
Speaker:
Selen Eyyupoglu
5:17 PM - 5:23 PM
Vulvovaginal Obliteration Secondary to Sexual Inactivity Syndrome: A Retrospective Analysis of 21 Cases (#073)
Speaker:
Lelia Yousif
5:23 PM - 5:29 PM
Shaping Outcomes: a Scoping Review of Gender Affirming Vaginoplasty Dilation Protocols (#074)
Speaker:
Mihir Kulkarni
4:05 PM - 5:30 PM
Palazzo Ballroom F-H
BPH, Reconstruction, Special Populations: Sexual Health Outcomes and Advances
Moderators:
Sarah Krzastek, MD, Paul Rusilko, DO, FACS & Charles Welliver, MD
4:05 PM - 4:20 PM
Sexual Dysfunction and LUTS in Diabetes: Big Data Sources
Speaker:
Aruna Sarma, PhD, MHA
4:20 PM - 4:35 PM
Ejaculocentrism - Choosing the Right BPH Procedure Based Procedure to Optimize Postoperative Sexual Function
Speaker:
Joseph Mahon, MD
4:35 PM - 4:55 PM
Integrating Sacral Neuromodulation into a Men's Health Practice
Speakers:
Adam Baumgarten, MD, MBA & Meghan Cooper, DO, MPH
4:55 PM - 5:05 PM
Sexual Function Recovery After Male and Female Pelvic Fracture
Speaker:
Niels Johnsen, MD, MPH, FACS
5:05 PM - 5:15 PM
Sexual Function after Surgical Management of Acquired Buried Penis
Speaker:
Paul Rusilko, DO, FACS
5:15 PM - 5:25 PM
The Future of Gender-Affirming Genital Surgery: Innovation and Sexual Function Outcomes
Speaker:
Wai Gin (Don) Lee, PhD, FRACS
5:25 PM - 5:30 PM
Q&A
5:30 PM - 6:30 PM
Mediterranean Ballroom 4
FUTURE Event (Non-CME)
5:30 PM - 6:30 PM
Foyer
COCKTAILS AND CONVOS: APP Networking & Mental Health Clinicians Mixer (Non-CME)
Saturday, October 10, 2026
7:00 AM - 8:00 AM
Mediterranean Ballroom 4
Breakfast - SMSNA Regional Interest Groups (non-CME)
7:00 AM - 8:00 AM
Palazzo Ballroom A-B
Industry Sponsored Breakfast Symposium (Non-CME)
8:00 AM - 10:00 AM
Mediterranean Ballroom 1-3
Plenary Session: Surgical
Moderators:
Petar Bajic, MD & Susan MacDonald, MD
8:00 AM - 8:10 AM
Mast Cell Disease and the Vestibule: Surgical Considerations
Speaker:
Alyssa Yee, MD
8:10 AM - 8:20 AM
What Shoud I Dip my Hydrophillic Implant In?
Speaker:
Paul Chung, MD
8:20 AM - 8:30 AM
When Should I Use a Malleable Prosthesis?
Speaker:
Gideon Blecher, MD
8:30 AM - 9:10 AM
Panel: Fix It or Leave It Alone? When Is It Appropriate to Revise a Functional Penile Implant
Moderator:
Sevann Helo, MD
Mentors:
Jonathan Clavell Hernandez, MD, Sherita King, MD, John Mulcahy, MD, PhD & Paul Perito, MD
9:10 AM - 9:20 AM
Challenges in ProlongedIischemic Priapism - Surgical Considerations
Speaker:
Juan Andino, MD, MBA
9:20 AM - 9:50 AM
Debate: 55 Degree Ventral Penile Curvature and Normal Baseline Erectile Function (CCH vs Plication vs Grafting vs IPP)
Characterizing Penile Implant Infections at Scale: Microbiology, Comorbidities, and Antibiotic Prescribing Patterns from the Epic Cosmos Database (#270)
Beyond Volume: Stromal Vascular Fraction Enrichment Improves Both Girth Retention and probably Erectile Function in Autologous Penile Fat Grafting (#271)
Speaker:
Marcos Sforza
10:18 AM - 10:21 AM
Regional Disparities in Inflatable Penile Prosthesis Reimbursement: Insights from Transparency in Coverage Data (#272)
Evaluating Drivers of Inflatable Penile Prosthesis Infection: The Impact of Operative Duration, Perioperative Hyperglycemia, and Intraoperative Irrigation Protocols (#273)
Sacral Neuromodulation Works in Men: Multi-Institutional Safety and Satisfaction Outcomes for Sacral Neuromodulation in Male Overactive Bladder Patients (#281)
Immune Checkpoint Inhibitors In Cancer Patients Are Associated With Lower Risk Of Low Testosterone And Need For Testosterone Replacement Therapy Relative To Gonadotoxic Chemotherapy (#285)
Undervaluation of Cognitive Care in Telehealth for Male Sexual and Reproductive Health: A National Analysis of Commercial and Medicare Reimbursement (#286)
Make No Bones About It: Aromatase Inhibitors Do Not Increase Osteoporosis Risk When Combined With Clomiphene Citrate in Men Wishing to Preserve Fertility (#287)
Validation of PROSE (Post-Radical Prostatectomy Overview of Sexual Experience): A New Multidimensional Patient Reported Outcome (PRO) to Assess Sexual Function following Radical Prostatectomy (RP) (#291)
The CLIMAX Registry: Design, Protocol, and Early Cohort Description — The First Prospective, Multicenter Registry for Delayed Ejaculation and Male Anorgasmia (#299)
Moderators:
Yooni Blair, MD & Wayne Hellstrom, MD, FACS
10:35 AM - 10:41 AM
Developing a Real-Time, Web-Based IPP Risk Calculator for Predicting Intraoperative, Noninfectious, and Infection-Related Complications (#089)
Speaker:
Muhammed A. Moukhtar Hammad
10:41 AM - 10:47 AM
Beyond Enlargement: Hyaluronic Acid for Penile Contour Restoration in Reconstructive Urology (#090)
Speaker:
Alfredo Suarez-sarmiento, Jr.
10:47 AM - 10:53 AM
Partner Dynamics: Assessing the Influence of Female Sexual Dysfunction on Male Satisfaction After Inflatable Penile Prosthesis (#091)
Speaker:
Lucas Amorim
10:53 AM - 10:59 AM
Permanent Penile Filler Complications: A Multinational Retrospective Analysis of Presentation Patterns and Surgical Burden (#092)
Speaker:
Alfredo Suarez-sarmiento, Jr.
10:59 AM - 11:05 AM
A Comparative Diffusion of Surgiphor and Rifampin on Hydrophillic BioFlex Implants (#093)
Speaker:
Tariq Hakky
11:05 AM - 11:11 AM
Extended Catheterization with Inflatable Penile Prosthesis: No Increased Risk of Erosion, Infection, or Malfunction (#094)
Speaker:
Nicklas Sarantos
11:11 AM - 11:17 AM
Characterizing Postoperative Penile Paresthesias Following Inflatable Penile Prosthesis Placement (#095)
Speaker:
Bailey Carter
11:17 AM - 11:23 AM
A Preoperative Prediction Tool for Long-Term Penile Length After Inflatable Penile Prosthesis: Regression Model and 3-Bin Clinical Lookup in a Single-Surgeon Series of 223 Patients (#096)
Speaker:
Edward Gheiler
11:23 AM - 11:29 AM
Long-Term Penile Length and Girth Gain Following Inflatable Penile Prosthesis Implantation Without Rehabilitation Protocols: A Single-Surgeon, Four-Rater Blinded Consecutive Series (#097)
Speaker:
Edward Gheiler
11:29 AM - 11:35 AM
Malleable versus Inflatable Penile Prosthesis in Ischaemic Priapism (#098)
Speaker:
Abdullah Al-Mitwalli
11:35 AM - 11:41 AM
Use of TYRX Antibacterial Envelope in Inflatable Penile Prosthesis Surgery: A Prospective Pilot Study (#099)
Speaker:
Adam Schneider
11:41 AM - 11:47 AM
Impact of Penile Prosthesis Implantation on Ejaculation Latency: A Comparative Analysis of Infrapubic, Penoscrotal, and Subcoronal Approaches (#100)
Speaker:
Zulfu Sertkaya
11:47 AM - 11:53 AM
Cost Impact Analysis of TYRX Absorbable Antibacterial Envelope for Inflatable Penile Prosthesis Surgery (#101)
Speaker:
James Um
11:53 AM - 11:59 AM
Inflatable Penile Prosthesis Injury Following Cosmetic Penile Augmentation: An International Multicenter Study of an Emerging Patient Safety Concern (#102)
Speaker:
Alfredo Suarez-sarmiento, Jr.
10:40 AM - 12:00 PM
Palazzo Ballroom C
APP Session Part 2 - Hands-on
Moderators:
Stephen Carlson, CNP & Kristy Mardis, NP
Moderators:
Sue Goldstein, BA, CCRC, AASECT-CSE, IF & Daniel Watter, PhD, IF
1:30 PM - 1:40 PM
AUA Guideline of Disorders of Ejaculation - What is New With the 2026 Updates
Speaker:
Petar Bajic, MD
1:40 PM - 2:10 PM
Panel: Redefining Our Definition of Orgasm
Moderator:
Alan Shindel, MD
Mentors:
Irwin Goldstein, MD, IF, Sue Goldstein, BA, CCRC, AASECT-CSE, IF & Barry Komisaruk, PhD
2:10 PM - 2:25 PM
Not Just for Young Women Anymore: The Expanding Case for Flibanserin Across Ages and Sexes
Speaker:
Jessica Yih, MD
2:25 PM - 2:50 PM
Psychosocial & Cultural Insights (Funded by the MAP Lectures Fund)
Speaker:
Rachel Needle, PsyD
2:50 PM - 3:15 PM
SSTAR Lecture - Demystifying Delayed Ejaculation
Speaker:
Stephen Snyder, MD
3:15 PM - 3:30 PM
Q&A
1:30 PM - 3:30 PM
Palazzo Ballroom A-B
Peyronie's Abstract Session
Moderators:
Lawrence Jenkins, MD, MBA, FACS & Laurence Levine, MD
1:30 PM - 1:36 PM
Satisfaction Scores Following Inflatable Penile Prosthesis Implantation with Straightening Maneuvers for Peyronie’s Disease Are Comparable to Those Following Non-Peyronie’s Cases (#103)
Speaker:
Marcelo Mass Lindenbaum
1:36 PM - 1:42 PM
Safety and Efficacy of a Modified “Scratch” Technique Using a Dental Pick (#104)
Speaker:
Bailey Carter
1:42 PM - 1:48 PM
Reconstruction of the Prepuce Following Circumcision Using a Novel Surgical Technique (#105)
Speaker:
Abdullah Al-Mitwalli
1:48 PM - 1:54 PM
Safety of Repeated Intraoperative Modeling During Inflatable Penile Prosthesis Placement for Peyronie’s Disease (#106)
Speaker:
Samuel Ryan Sorkhi
1:54 PM - 2:00 PM
Safety and Efficacy of Minimally Invasive Intracorporeal Incision of Peyronie’s Plaque During Inflatable Penile Prosthesis Placement (#107)
Speaker:
Bailey Carter
2:00 PM - 2:06 PM
Penile Plication for Severe Peyronie’s Disease: Safe, Effective, and Associated with High Patient Satisfaction (#108)
Speaker:
James A. Malony
2:06 PM - 2:12 PM
Low Surgical Utilization After Collagenase Clostridium Histolyticum for Peyronie’s Disease: Associated Factors in a Multicenter Real-World Cohort (#109)
Speaker:
Jake Miller
2:12 PM - 2:18 PM
Maximal Inflation Protocol Adherence Following Inflatable Penile Prosthesis Placement for Peyronie’s Disease is not Associated with Postoperative Complications (#110)
Speaker:
Samuel Ryan Sorkhi
2:18 PM - 2:24 PM
Implementation of Modified Trost Protocol Results in Greater Curvature Improvement with Fewer Collagenase Clostridium Histolyticum Cycles (#111)
Speaker:
Marcelo Mass Lindenbaum
2:24 PM - 2:30 PM
Sex Positions and Symptom Severity in Peyronie's Disease (#112)
Speaker:
Kiera Liblik
2:30 PM - 2:36 PM
Efficacy of a Novel Collagenase Clostridium Histolyticum Protocol for Peyronie’s Disease Among Prior Non-responders: A Randomized, Controlled, Single-Blinded Study – Final Results (#113)
Speaker:
Ryan Nigbur
2:36 PM - 2:42 PM
Comparison of Collagenase Clostridium Histolyticum to Surgery for the Management of Peyronie’s Disease: A Randomized Trial – 4 Year Outcomes (#114)
Speaker:
Landon Trost, MD
2:42 PM - 2:48 PM
Manchester Visual Analogue Scale (MVAS) for Assessment of Penile Curvature in Peyronie's Disease: The Preliminary Results of a Multicentre Validation Study (#115)
Speaker:
Mohamed Mubarak
2:48 PM - 2:54 PM
Do Conservatively Managed Penile Fractures During Collagenase Clostridium Histolyticum Therapy Impact Subsequent Erectile Function? (#116)
Speaker:
Olivia Johnson
2:54 PM - 3:00 PM
Optimizing Intralesional Collagenase Therapy for Peyronie’s Disease: Early Institutional Experience with a Modified Protocol (#117)
Speaker:
Lucas Amorim
3:00 PM - 3:06 PM
Stretched Penile Length Changes After Collagenase Clostridium Histolyticum Treatment for Peyronie’s Disease: A Retrospective Cohort Study (#118)
Speaker:
Dyvon Walker
3:06 PM - 3:12 PM
Anti-TNF Biologics and Incident Peyronie's Disease: A Propensity-Matched Cohort Study (#119)
Speaker:
Lawrence Jenkins, MD, MBA, FACS
3:12 PM - 3:18 PM
Surgical De-escalation After Collagenase for Peyronie's Disease (#120)
Speaker:
Lawrence Jenkins, MD, MBA, FACS
3:18 PM - 3:24 PM
Factors Associated with Subjective Worsening of Erectile Function Post Collagenase Clostridium Histolyticum Therapy (#121)
Real-World Device Utilization and Sexual-Activity Frequency After Inflatable Penile Prosthesis Without Rehabilitation Protocols: High Ongoing Use and No Association Between Cycling Frequency and Long-Term Length Gain (#307)
Are Satisfaction Rates After Primary Inflatable Penile Prosthesis Surgery Overestimated? An International Multicenter Study Using a Validated Patient-Reported Outcome Measure (#308)
Speaker:
Abdullah Al-Mitwalli
3:39 PM - 3:42 PM
Pudendal Nerve Block Versus Spinal Anesthesia for Malleable Penile Prosthesis Implantation: A Comparative Study (#309)
Predicting Post-Prostatectomy Erectile Dysfunction to Enable Timely Sexual Medicine Intervention: A Machine Learning–Enabled Analysis of Objective Performance Indicators (#312)
Clinical Characteristics and Treatment Patterns in Men with Peyronie's Disease Undergoing Procedural Intervention at a Tertiary Andrology Clinic (#326)
Objective Improvement in Mild Penile Curvature Following Penile Traction Therapy: Functional and Psychosexual Outcomes From a Prospective Pilot Case Series (#329)
Paclitaxel Drug-Coated Balloon Dilation in Patients with Penile Prostheses, Artificial Urinary Sphincters, and ProACT Devices: A Single-Institution Experience (#341)
Comparison of Patient Reported Outcome Measures in Patients with Symptoms of Hard Flaccid Syndrome (HFS) Versus Control Patients Without HFS Symptoms (#344)
Medical Student Forum (Resident Run-Medical Student and Resident Committee) (Non-CME)
Moderator:
Ellen Cahill, MD
4:05 PM - 5:05 PM
Palazzo Ballroom F-H
BPH, Reconstruction, Fertility Abstracts
Moderators:
Bryce Baird, MD & David Shin, MD
4:05 PM - 4:11 PM
Ejaculatory Function and Bother After the ProVee Prostatic Urethral Stent for Benign Prostatic Hyperplasia: Results from the ProVIDE Study (#122)
Speaker:
Michelle Ouviña-Ryan
4:11 PM - 4:17 PM
Comparative Analysis of REM Sleep Duration in Patients with Nocturia Due to BPH, TURP, and HoLEP Using Wearable-Derived Data (#123)
Speaker:
Hana Nakamura
4:17 PM - 4:23 PM
Lateral Fluoroscopy During Adjustable Continence Therapy (ProACTTM) Implantation Improves Initial Continence Outcomes and Reduces Device Revision (#124)
Speaker:
Vincent Hou
4:23 PM - 4:29 PM
The Impact of Prednisone on Post-operative Vasectomy Reversal Semen Parameters (#125)
Speaker:
Alissa Tyler
4:29 PM - 4:35 PM
High-Frequency Ultrasound Testicular Micro-Mapping and High-Throughput Sperm Search in the Management of Non-Obstructive Azoospermia: A Pilot Study (#126)
Speaker:
Blair Stocks
4:35 PM - 4:41 PM
Longitudinal Sexual Health and Intercourse Safety in Singleton Pregnancies Conceived via Assisted Reproductive Technology (#127)
Speaker:
Guanjian Li
4:41 PM - 4:47 PM
Effects of Chronic Psilocybin on Scrotal Volume and Semen Parameters (#128)
Speaker:
Daye Park
4:47 PM - 4:53 PM
Reproducible Silicone-Based 3D Models Mimic Human Vas Deferens with Appropriate Softness and Tensile Properties for Urological Training and Education (#129)
Speaker:
Boyang Zhang
4:53 PM - 4:59 PM
Association Between 5α-Reductase Inhibitor Therapy and Risk of Depression and Intentional Self-Harm in Men with Benign Prostatic Hyperplasia: A Nationwide Matched Cohort Study (#130)
Speaker:
Suntae Ahn
4:59 PM - 5:05 PM
Restoration of Continence with Adjustable Continence Therapy (ProACT™) Improves Quality of Life and Sexual Function in Men With Stress Urinary Incontinence (SUI) (#131)
Speaker:
Vincent Hou
4:05 PM - 5:30 PM
Palazzo Ballroom C
SLAMS/AMA Spanish-Language Session Part 2 (Non-CME)
Moderator:
Juan Andino, MD, MBA
4:05 PM - 4:15 PM
Liderazgo en Andrologia
Speaker:
Pedro Maria, DO
4:15 PM - 4:27 PM
Efectos Sexuales de los Medicamentos para HPB
Speaker:
Manuel Belmonte Chico Goerne, MD
4:27 PM - 4:39 PM
Efectos Sexuales de las Cirugias para HPB
Speaker:
Edwin Reyes, MD
4:39 PM - 4:51 PM
Satisfaccion del Paciente Despues del Implante Peniano
Speaker:
Alejandro Carvajal, MD, FECSM
4:51 PM - 5:02 PM
Incontinencia Sexual Masculina
Speaker:
Nicolas Ortiz, MD, FACS
5:02 PM - 5:15 PM
Q&A
5:15 PM - 5:20 PM
Drenaje Dual de Succión Cerrada Tras la Implantación de Prótesis Peneana Inflable: Impacto sobre la Formación de Hematomas, la Equimosis y la Recuperación Postoperatoria
Speaker:
Alfredo Suarez-sarmiento, Jr.
5:20 PM - 5:25 PM
Obliteración Vulvovaginal: Una Manifestación Grave del Síndrome Asexual de la Menopausia
Speaker:
Ziomara Machado
5:25 PM - 5:30 PM
Barreras en el Examen de Cáncer de Mama y Cérvix en Personas Transgéneros y No Binarias AFAB
Speaker:
Ziomara Machado
4:05 PM - 5:30 PM
Mediterranean Ballroom 1-3
Challenging Cases Panel; Golden Nut Award; Closing Remarks (Non-CME)
Moderators:
Marah Hehemann, MD & Matthew Ziegelmann, MD
4:05 PM - 4:50 PM
Panel: My Most Challenging Cases
Moderators:
Marah Hehemann, MD & Elizabeth Phillips, MD
Depression, Anxiety, and Suicide Risk Across Major Male Urologic Conditions: An Umbrella Synthesis of Meta-Analytic Evidence and a Proposed Sexual Medicine Mental Health Screening Toolkit (#153)
Conversational AI and Antidepressant-Related Sexual Dysfunction: A Scoping Review and Proposed Counseling Quality Rubric for Integrated Sexual Medicine Care (#213)
How Does Severe Obesity Affect Postoperative Complications following Inflatable Penile Prosthesis Placement? A Single-Institution Retrospective Review (#366)
Circumcorporal Artificial Urinary Sphincter (CC-AUS): Update of a Novel Surgical Approach for the Treatment of Complex Male Stress Urinary Incontinence (SUI) (#369)
Artificial Intelligence in Men’s Health: Comparative Evaluation of ChatGPT and Grok in Addressing the Psychological Aspects of Erectile Dysfunction (#374)
Impact of State Insurance Mandates on Disparities in Assisted Reproductive Technology Utilization: A Comparative Epidemiological Analysis of New York State (#377)
Long-Term Penile Length Gain After Inflatable Penile Prosthesis Is Not Predicted by Patient, Comorbidity, Device, or Cylinder-Sizing Factors: Multivariable Analysis of a Single-Surgeon Series of 223 Consecutive Patients (#378)
Randomized, Controlled, Open Label, Multi-Center, Non-inferiority IDE Clinical Investigation Evaluating Safety and Effectiveness of Signati Separo™ Vessel Sealing System compared to Mucosal Cautery Vasectomy (Control) (#382)
Which Prostatic Bladder Outlet Surgeries Are Associated with Improved Outcomes in Men with Benign Prostatic Hyperplasia and Detrusor Underactivity? (#391)
Evaluating Demographic Predictors of High Pornography Craving Risk Among Jordanian Adults: A Cross-Sectional Analysis Using the Pornography Craving Questionnaire (#396)
Speaker:
Yaman Altal
Navigating the Choice for Penile Prosthesis: An Application of the Health Belief Model to Understand Barriers and Motivators Among Jordanian Men with Erectile Dysfunction (#397)
Speaker:
Yaman Altal
Urinary and Sexual Outcomes Following HoLEP, TURP, Rezum, and UroLift for BPH: A Single Institution Study (#398)
Outcomes Of Inflatable Penile Prosthesis Implantation in Men with Prior Radiation Therapy: A Propensity-Matched Analysis of a Federated Real-World Database (#399)
Premature Ejaculation Is More Closely Associated with Psychosexual Burden than with a Simple Vitamin D Deficiency Pattern (#409)
Speaker:
Mustafa Kadihasanoglu
Surgical Management of Inguinal Hernias in the Setting of Penile Implant Reservoirs and Artificial Urinary Sphincter Pressure Regulating Balloons (#410)
Evaluating of the Correlation Between Oxidative Stress and Other Semen Parameters: the Value of Oxidative Stress Assessment in the Evaluation of Male Infertility (#417)
How Restricted Education and Lack of Support for Female Sexual Pleasure Affect the Health of Perimenopausal and Menopausal Women in the Middle East (#422)
An Interpretable Machine-Learning Framework to Predict Post-Bariatric Testosterone Change in Male Obesity-Associated Secondary Hypogonadism: A Proof-of-Concept Proposal for an Understudied Middle Eastern Population (#427)
Semaglutide Improves Cardiometabolic Dysfunction and Directly Relaxes the Pudendal Artery in Early-Life Obesity: Implications for Erectile Dysfunction (#433)
Testicular Tissue Cryopreservation for Fertility Preservation in Pre- and Peripubertal Males Undergoing Gonadotoxic Therapy (#438)
Speaker:
Nikola Rakic
Racial, Sexual Orientation, and Socioeconomic Disparities in Testicular Examination Among U.S. Men: Structural and Attitudinal Barriers to Preventive Care (#439)
Attention: Restrictions on use of SMSNA content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
